Generation and fluorescent formatting of aptamers targeting antiretroviral drugs (ARVs) for the detection of unreported ARV use on behalf of the CDC’s National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention Division of HIV Prevention.
The CDC intends to award a sole-source contract to Texas A&M University for generating and formatting aptamers to detect antiretroviral drugs (ARVs) for HIV surveillance and blood safety monitoring. This requirement supports the development of a high-throughput, aptamer-based assay that overcomes the cost and scalability limitations of current laboratory methods. The anticipated period of performance is a two-year contract running from August 3, 2026, through August 13, 2028. No budget amount is specified in the description. This notice is issued solely to determine if other responsible sources exist; the government will not publish a solicitation.